Higher anticoagulation targets and risk of thrombotic events in severe COVID-19 patients: bi-center cohort study

BACKGROUND: Thromboprophylaxis of COVID-19 patients is a highly debated issue. We aimed to compare the occurrence of thrombotic/ischemic events in COVID-19 patients with acute respiratory distress syndrome (ARDS) treated with either prophylactic or therapeutic dosage of heparin. All patients referre...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Ann Intensive Care
Auteurs principaux: Helms, Julie, Severac, François, Merdji, Hamid, Schenck, Maleka, Clere-Jehl, Raphaël, Baldacini, Mathieu, Ohana, Mickaël, Grunebaum, Lélia, Castelain, Vincent, Anglés-Cano, Eduardo, Sattler, Laurent, Meziani, Ferhat
Format: Artigo
Langue:Inglês
Publié: Springer International Publishing 2021
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7829649/
https://ncbi.nlm.nih.gov/pubmed/33492445
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13613-021-00809-5
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires